Browsing Tag
Sixth Street
5 posts
One-time gene correction therapy BEAM-302 reaches pivotal AATD testing
BEAM-302 enters pivotal AATD testing as Beam Therapeutics targets accelerated approval with $1.2 billion in cash and new data due in September.
BridgeBio raises $1bn in preferred equity to fund rare disease product launches
BridgeBio’s $1 billion preferred equity raise strengthens BBIO’s balance sheet as Attruby grows and three rare disease launches approach.
BridgeBio Pharma weighs $1bn KKR, Sixth Street preferred equity deal as launch costs rise
BridgeBio Pharma may be preparing its balance sheet for three potential product launches, but the value of a $1 billion preferred equity deal will depend heavily on its undisclosed dividend, conversion and redemption terms.
Sixth Street to acquire global insurer Enstar Group in blockbuster $5.1bn deal
Enstar Group Limited (Nasdaq: ESGR) has announced a definitive merger agreement with Sixth Street, marking a significant move…
Sixth Street, BGH Capital to acquire payments company Pushpay Holdings for $898m
A consortium consisting of Sixth Street and BGH Capital has signed an agreement to acquire New Zealand-based payments…